RNA-Based next generation sequencing complements but does not replace fluorescence in situ hybridization studies for the classification of aggressive B-Cell lymphomas.

[1]  K. Elenitoba-Johnson,et al.  Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas. , 2020, Cold Spring Harbor perspectives in medicine.

[2]  Qin Huang,et al.  High-Grade B-Cell Lymphoma , 2020, Practical Lymph Node and Bone Marrow Pathology.

[3]  S. Bens,et al.  Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of “MYC-negative” Burkitt lymphoma , 2020, Haematologica.

[4]  J. Choi,et al.  Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next‐generation sequencing approaches , 2019, Hematological oncology.

[5]  E. Severson,et al.  Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas. , 2019, American journal of clinical pathology.

[6]  Ryan D. Morin,et al.  --The double hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. , 2019, Blood.

[7]  C. Mullighan,et al.  The Biology of B-Progenitor Acute Lymphoblastic Leukemia. , 2019, Cold Spring Harbor perspectives in medicine.

[8]  David M. Thomas,et al.  Diagnosis of fusion genes using targeted RNA sequencing , 2019, Nature Communications.

[9]  J. Choi,et al.  Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies. , 2019, The Journal of molecular diagnostics : JMD.

[10]  J. Cook,et al.  Identification of “Double Hit” Lymphomas Using Updated WHO Criteria: Insights From Routine MYC Immunohistochemistry in 272 Consecutive Cases of Aggressive B-Cell Lymphomas , 2019, Applied immunohistochemistry & molecular morphology : AIMM.

[11]  L. Rimsza,et al.  Genomics of aggressive B-cell lymphoma. , 2018, Hematology. American Society of Hematology. Education Program.

[12]  J. Cortes,et al.  Acute myeloid leukaemia , 2018, The Lancet.

[13]  Asha A. Nair,et al.  Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. , 2018, Blood.

[14]  Saijuan Chen,et al.  Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia , 2017, Proceedings of the National Academy of Sciences.

[15]  J. Passweg,et al.  Acute myeloid leukaemia genomics , 2017, British journal of haematology.

[16]  G. Ott.  Aggressive B‐cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings , 2017, British journal of haematology.

[17]  O. Abdel-Wahab,et al.  Diagnosis and classification of hematologic malignancies on the basis of genetics. , 2017, Blood.

[18]  A. Feldman,et al.  Lymphoma classification update: B-cell non-Hodgkin lymphomas , 2017, Expert review of hematology.

[19]  Lars Bullinger,et al.  Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Y. Denizot,et al.  The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis , 2016, Oncotarget.

[21]  Rosamaria Pinto,et al.  Next-generation sequencing: advances and applications in cancer diagnosis , 2016, OncoTargets and therapy.

[22]  Angie Duy Vo,et al.  Identifying fusion transcripts using next generation sequencing , 2016, Wiley interdisciplinary reviews. RNA.

[23]  J. Carpten,et al.  Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.

[24]  Lauren C. Chong,et al.  Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression. , 2015, Cell reports.

[25]  B. Coiffier,et al.  Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. , 2015, The Lancet. Oncology.

[26]  K. Savage,et al.  The biology and management of systemic anaplastic large cell lymphoma. , 2015, Blood.

[27]  Laura Pasqualucci,et al.  The genetic landscape of diffuse large B-cell lymphoma. , 2015, Seminars in hematology.

[28]  A. Feldman,et al.  Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous , 2015, Advances in anatomic pathology.

[29]  S. Swerdlow.  Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. , 2014, Hematology. American Society of Hematology. Education Program.

[30]  Jie Zheng.  Oncogenic chromosomal translocations and human cancer (review). , 2013, Oncology reports.

[31]  A. Ariza,et al.  MYC status determination in aggressive B‐cell lymphoma: the impact of FISH probe selection , 2013, Histopathology.

[32]  L. Medeiros,et al.  B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome , 2012, Modern Pathology.

[33]  M. Neat,et al.  Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience , 2011, Journal of Clinical Pathology.

[34]  Steven J. M. Jones,et al.  MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers , 2011, Nature.

[35]  Matija Snuderl,et al.  B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma , 2010, The American journal of surgical pathology.

[36]  F. Jardin,et al.  Promoter Shuffling by Sequential Genomic Rearrangements in Follicular Lymphoma Reveals an Ongoing Genomic Instability at the BCL6 Locus. , 2006 .

[37]  Takashi Akasaka,et al.  BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. , 2003, Blood.

[38]  Riccardo Dalla-Favera,et al.  Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.

[39]  G. Srivastava,et al.  Identification and characterization of BCL6 translocation partner genes in primary gastric high‐grade B‐cell lymphoma: Heat shock protein 89 alpha is a novel fusion partner gene of BCL6 , 2000, Genes, chromosomes & cancer.

[40]  M. Seto,et al.  Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5′-RACE and LA – PCR analyses of biopsy samples , 1999, Oncogene.